Ready to Buy Nvidia Stock? Check Out This Option.

    Key Points Nvidia’s financials continue to improve. Its GPUs are in high demand from AI companies. If you’re unsure whether to load up on Nvidia stock now, another option is dollar-cost averaging — putting smaller investments on auto-pilot. 10 stocks we like better than Nvidia › Nvidia (NASDAQ: NVDA) just finished up another great year….

    Read More

      Rupee falls 4 paise to 90.24 against U.S. dollar in early trade

      Image used for representation purpose only., | Photo Credit: Getty Images/iStockphoto The rupee opened weak and declined 4 paise to 90.24 against the U.S. dollar in early trade on Monday (January 5, 2026), as geopolitical uncertainties triggered by the U.S. intervention in Venezuela fuelled the demand for the American currency. According to forex traders, the…

      Read More

        Why Dylan Was Crushed Over Will on Jan. 2

        Eager to know the recap and spoilers for The Bold and the Beautiful for January 2? The episode begins with Bill telling Katie how proud he is of her for standing up to Brooke. Katie admits that Brooke’s constant condescension gets under her skin and pushed her to finally fight back. Meanwhile, Ridge and Brooke…

        Read More
        The ‘biology winter’ thaws: why investors are piling into Hong Kong’s biotech IPOs

          The ‘biology winter’ thaws: why investors are piling into Hong Kong’s biotech IPOs

          Hong Kong’s biotech fundraising momentum is expected to extend into 2026, as licensing deals and strong post-initial public offering (IPO) trading last year persuaded investors that China’s drug developers are worth backing again – even before they generate revenue. “Chinese innovation drugs expanding into overseas markets have become the industry mainstream, indicating the domestic innovation…

          Read More

            Don’t Buy Any Stock in 2026 Unless It Passes This Test

            Buffett provided great investing advice in his 2013 letter to Berkshire Hathaway shareholders. He identified a two-step process to determining whether or not to buy stocks that’s easy to understand but hard to execute. Two stocks that appear to pass Buffett’s hurdle now are AbbVie and Nucor. 10 stocks we like better than AbbVie ›…

            Read More